FindTrial
Sign In

Laparoscopic Liver Segmental and Subsegmental Resection From Segment 1 to Segment 8 Based on the Glissonean Pedicle Transection Method and the New Anatomical Segmentation of the Liver

Laparoscopic Liver Segmental and Subsegmental Resection From Segment 1 to Segment 8 Based on the Glissonean Pedicle Transection Method and the New Anatomical Segmentation of the Liver

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300073783
Enrollment
Unknown
Registered
2023-07-20
Start date
2023-07-20
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocellular carcinoma

Interventions

experimental group:None

Sponsors

Department of Hepatobiliary Surgery, The First Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with hepatocellular carcinoma who underwent laparoscopic hepatic segmental resection at the First Affiliated Hospital of Chongqing Medical University; 2. The diagnosis of the included patients was in accordance with stage Ia-IIa of the Chinese liver cancer diagnostic staging or stage 0-A of the Barcelona staging system.

Exclusion criteria

Exclusion criteria: 1, Patients who do not meet the above diagnosis and staging; 2. Patients who failed to undergo anatomical hepatectomy.

Design outcomes

Primary

MeasureTime frame
None;—

Countries

China

Contacts

Public ContactChengyou Du, Xiang Lan

Department of Hepatobiliary Surgery, The First Hospital of Chongqing Medical University

lanxiang_tmmu@163.com+86 136 2978 0427

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026